CU
Clinuvel
CUV.AX·ASXMelbourne AUFounded 1991150 employees
Small CapbiotechPublicRare DiseaseDermatology
Platform: Melanocortin
Market Cap
$1.2B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (CUV.AX)
Loading CUV.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zenorasimod | CUV-3020 | Phase 2 | 1 | PRMT5 | PompeCSU | ||
| CUV-6674 | CUV-6674 | Phase 1/2 | 1 | IL-23 | MCL |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Clinuvel trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)